WINDWARD BIO GROUP AG

F-1 filed

DRS/A amended

The current filing for Windward Bio Group AG details the underwriters' option to purchase additional shares, lock-up agreements restricting share sales, stabilization activities, electronic distribution methods, and underwriter relationships. It emphasizes the 180-day lock-up period for insiders, restrictions on short sales, and the underwriters' potential market-making activities. The document also outlines exceptions to lock-up rules, such as gifts, estate transfers, and specific corporate actions.

DRS/A amended

Windward Bio Group AG has filed a DRS/A form for its initial public offering (IPO), detailing the underwriting agreement with Jefferies LLC, TD Securities (USA) LLC, Piper Sandler & Co., and UBS Securities LLC. The offering includes terms for common share purchases, underwriting discounts, and a 180-day lock-up period for insiders. The company plans to list on Nasdaq under the symbol "WWB." The filing also outlines stabilization activities, market-making intentions, and risks related to liquidity and price volatility.

DRS/A amended

Windward Bio Group AG has filed a DRS/A form for its initial public offering (IPO), detailing the underwriting agreement with Jefferies LLC, TD Securities (USA) LLC, Piper Sandler & Co., and UBS Securities LLC. The underwriters will purchase common shares at an undisclosed public offering price, with terms including conditions precedent, indemnification clauses, and market-making intentions. The offering includes an option for underwriters to purchase additional shares, and the company plans to list on Nasdaq under the symbol "WWB." The filing also outlines lock-up agreements for insiders and potential stabilization activities by underwriters.

DRS filed

Windward Bio Group AG has filed a Draft Registration Statement (DRS) for an initial public offering (IPO), outlining the underwriting agreement with Jefferies LLC, TD Securities (USA) LLC, Piper Sandler & Co., and UBS Securities LLC. The offering involves the sale of common shares at an unspecified price, with underwriters reserving the right to adjust terms. The company plans to list on Nasdaq under the symbol "    ". A 180-day lock-up period restricts insiders from selling shares, and stabilization activities may influence post-IPO pricing. No prior filings exist for comparison.